United States - English - NLM (National Library of Medicine)

kavi skin solutions, inc. - sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70), salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - colloidal sulfur 2% (equivalent to precipitated sulfur 10%)…...acne treatment salicylic acid 3%.........................................acne treatment uses for the treatment and prevention of oily, acne-prone skin directions ▪ use as a replacement to your existing cleanser(s) ▪ lather using warm water and cleanse affected areas ▪ rinse and pat dry ▪ cleanse once to three times per day ▪ monitor skin for dryness or irritation and reduce application as needed for the treatment and prevention of oily, acne-prone skin drug facts active ingredients/purpose colloidal sulfur 2% (equivalent to precipitated sulfur 10%)…...acne treatment salicylic acid 3%.........................................acne treatment uses for the treatment and prevention of oily, acne-prone skin warnings ▪ for external use only ▪ keep out of reach of children when using this product avoid other antiseborrheics unless otherwise directed by your physician. use in conjunction with other oral

United States - English - NLM (National Library of Medicine)

kavi skin solutions, inc. - sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - colloidal sulfur 1% (equivalent to precipitated sulfur 5%)…...acne treatment uses for the treatment and prevention of oily, acne-prone skin directions ▪ use as a replacement to your existing cleanser(s) ▪ lather using warm water and cleanse affected areas ▪ rinse and pat dry ▪ cleanse once to three times per day ▪ monitor skin for dryness or irritation and reduce application as needed for the treatment and prevention of oily, acne-prone skin drug facts active ingredients/purpose colloidal sulfur 1% (equivalent to precipitated sulfur 5%)…...acne treatment uses for the treatment and prevention of acne or as a non-inflammatory cleanser on skin diagnosed with eczema, rosacea, psoriasis, or other condition requiring a ph-balancing topical warnings ▪ for external use only ▪ keep out of reach of children when using this product avoid other antiseborrheics unless otherwise directed by your physician. use in conjunction with other oral or topical anti-acne drugs may increas

United States - English - NLM (National Library of Medicine)

kavi skin solutions, inc. - octyl-p-methoxycinnamate (7.5%), benzophenone-3 (6%). - moisturizing and clarifying skin while shielding it from the sun, kavi spf 30 is a 3-in-1 solution to skin rejuvenation and preservation. completely oil and paba free, kavi spf 30 is non-comedogenic (does not clog pores) and still waterproof. suitable for daily use, and an excellent form of broad-spectrum uva/uvb protection when treating the skin with kavi exfoliation masks. apply a layer of lotion to clean, dry skin twice per day or as necessary.

United States - English - NLM (National Library of Medicine)

kavi skin solutions, inc. - active ingredient: precipitated sulfur (6.6%). - designed exclusively for nodular and cystic acne, the kavi organic sulfur suspension helps to achieve two important results: (1) the accelerated treatment of acne infection within pores, and (2) the dissolution of free acne and other bacteria on the surface of the skin. the organic sulfur suspension has many of the same benefits as our anti-acne cleansers. in a liquid suspension and without the cleansing ingredients, our sulfur can now be left on the skin throughout the day. to offset sulfur's scent, we've added camphor to give the suspension a soothing essence. the kavi organic sulfur suspension is best suited for the treatment of acne-prone skin. directions: apply to skin one to two times per day after cleansing with a kavi anti-acne cleanser (e.g., coral kavi or dermawash s2). reduce frequency of application if skin becomes too dry.

United States - English - NLM (National Library of Medicine)

kavi skin solutions, inc. - active ingredients: cucumis sativus (cucumber) extract (3%), salicylic acid (0.2%). - made with cucumber extract and salicylic acid, the kavi toner is an ideal final-stage cleanser for individuals with reactive skin conditions such as acne, rosacea, eczema, and psoriasis. cucumber extract, a powerful antioxidant rich in vitamins a, c, e, and k, will help to soothe irritated skin and reduce swelling. salicylic acid will help to reduce pore diameter, exfoliate dead skin cells, and remove any remaining dirt, oil, or bacteria inside pores. when used daily, the kavi toner also provides an excellent preventive measure against blackhead formation. made with cucumber extract and salicylic acid, the kavi toner is an ideal final-stage cleanser for individuals with reactive skin conditions such as acne, rosacea, eczema, and psoriasis. directions: 1. rinse hands and face with warm water. 2. cleanse face with a kavi cleanser. 3. pat skin dry. 4. dampen cotton pad with kavi toner. 5. apply pad to skin in light circular motion, removing residual dirt, bacteria, and makeu

United States - English - NLM (National Library of Medicine)

kavi skin solutions, inc. - active ingredient: colloidal sulfur (1%) - kavi dermawash provides an ideal approach to cleansing normal or combination skin with ph sensitivity. dermawash utilizes allergy-tested ingredients that are non-comedogenic, ph-balancing, and completely free of animal products. frequent washing will not cause dryness or irritation, and dermawash will not aggravate rosacea, eczema, psoriasis, and many varieties of skin allergies. dermawash is made with colloidal sulfur to enhance the hydrolipidic layer’s acidity and protect skin from bacterial infections. suitable for use on the face and body, it is easy on the senses and a practical replacement to traditional animal-based soaps. designed for daily use, dermawash can also serve as an ideal cleanser for pre-peel preparation of skin. dermawash is best suited for the treatment of acne-prone skin. directions: 1. rinse face and/or body with warm water. 2. dispense 1 to 2 pumps of cleanser onto palm or washcloth. 3. rub palms or washcloth together, spreading cleanser evenly and buil

United States - English - NLM (National Library of Medicine)

kavi skin solutions, inc. - active ingredient: colloidal sulfur (2%) - designed for daily use, kavi dermawash s2 provides an ideal approach to cleansing oily or combination skin. dermawash s2 utilizes allergy-tested ingredients that are non-comedogenic, ph-balancing, and completely free of animal products. with the same dosage of sulfur as coral kavi, dermawash s2 is best suited for the treatment of acne-prone skin. dermawash s2 can be also used in preparation of the skin prior to administration of a kavi chemical peel. dermawash s2 is best suited for the treatment of acne-prone skin. directions: 1. rinse face and/or body with warm water. 2. dispense 1 to 2 pumps of cleanser onto palm or washcloth. 3. rub palms or washcloth together, spreading cleanser evenly and building a lather. 4. cleanse skin gently but thoroughly. 5. rinse face and/or body with warm water.

Israel - English - Ministry of Health

novartis israel ltd - ruxolitinib as phosphate - tablets - ruxolitinib as phosphate 5 mg - ruxolitinib - ruxolitinib - * * myelofibrosis (mf) jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. * polycythaemia vera (pv) jakavi is indicated for the treatment of adult patients with polycythaemia vera who are resistant to or intolerant of hydroxyurea.*graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies

Israel - English - Ministry of Health

novartis israel ltd - ruxolitinib as phosphate - tablets - ruxolitinib as phosphate 15 mg - ruxolitinib - ruxolitinib - * myelofibrosis (mf) jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. * polycythaemia vera (pv) jakavi is indicated for the treatment of adult patients with polycythaemia vera who are resistant to or intolerant of hydroxyurea.*graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies

Israel - English - Ministry of Health

novartis israel ltd - ruxolitinib as phosphate - tablets - ruxolitinib as phosphate 20 mg - ruxolitinib - ruxolitinib - * myelofibrosis (mf) jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. * polycythaemia vera (pv) jakavi is indicated for the treatment of adult patients with polycythaemia vera who are resistant to or intolerant of hydroxyurea.*graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies